The global Patient Derived Xenograft Models market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Patient Derived Xenograft Models volume and value at global level, regional level and company level. From a global perspective, this report represents overall Patient Derived Xenograft Models market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Patient Derived Xenograft Models in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Patient Derived Xenograft Models manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Crown Bioscience Inc. (US)
WuXi AppTec (China)
Champions Oncology, Inc. (US)
The Jackson Laboratory (US)
ONCODESIGN (France)
Charles River Laboratories International, Inc. (US)
EPO Berlin-Buch GmBH (Germany)
Shanghai LIDE Biotech Co., Ltd (China)
Xentech (France)
Horizon Discovery Group PLC (UK)
Urolead (France)
Explora BioLabs (US)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Mice Models
Rat Models

Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions